|
|
||||||||


* Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037; and
Partners AIDS Research Center, Massachusetts General Hospital and Division of AIDS, Harvard Medical School, Boston, MA 02115
Many components contribute to immunodominance in the response to a complex virus, but their relative importance is unclear. This was addressed using vaccinia virus and HLA-A*0201 as the model system. A comprehensive analysis of 18 viral proteins recognized by CD8+ T cell responses demonstrated that approximately one-fortieth of all possible 9- to 10-mer peptides were high-affinity HLA-A*0201 binders. Peptide immunization and T cell recognition data generated from 90 peptides indicated that about one-half of the binders were capable of eliciting T cell responses, and that one-seventh of immunogenic peptides are generated by natural processing. Based on these results, we estimate that vaccinia virus encodes
150 dominant and subdominant epitopes restricted in by HLA-A*0201. However, of all these potential epitopes, only 15 are immunodominant and actually recognized in vivo during vaccinia virus infection of HLA-A*0201 transgenic mice. Neither peptide-binding affinity, nor complex stability, nor TCR avidity, nor amount of processed epitope appeared to strictly correlate with immunodominance status. Additional experiments suggested that vaccinia infection impairs the development of responses directed against subdominant epitopes. This suggested that additional factors, including immunoregulatory mechanisms, restrict the repertoire of T cell specificities after vaccinia infection by a factor of at least 10.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by National Institutes of Health Grants ROI-AI-56268 (to A.S.), HHSN266200400124C (to A.S.), and ROI-AI-067077 (to C.B.). E.A. was supported by the Wenner-Gren Foundations. This is Kirin Publication 843.
2 Address correspondence and reprint requests to Dr. Alessandro Sette, Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037. E-mail address: alex{at}liai.org
3 Abbreviations used in this paper: VACV, vaccinia virus; ORF, open reading frame; DC, dendritic cell; SFC, spot-forming cell; Tg, transgenic; WR, Western Reserve.
4 The on-line version of this article contains supplemental material.
This article has been cited by other articles:
![]() |
A. Camarca, R. P. Anderson, G. Mamone, O. Fierro, A. Facchiano, S. Costantini, D. Zanzi, J. Sidney, S. Auricchio, A. Sette, et al. Intestinal T Cell Responses to Gluten Peptides Are Largely Heterogeneous: Implications for a Peptide-Based Therapy in Celiac Disease J. Immunol., April 1, 2009; 182(7): 4158 - 4166. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Rao, A. I. C. A. Fontaine Costa, D. van Baarle, and C. Kesmir A Comparative Study of HLA Binding Affinity and Ligand Diversity: Implications for Generating Immunodominant CD8+ T Cell Responses J. Immunol., February 1, 2009; 182(3): 1526 - 1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Assarsson, H.-H. Bui, J. Sidney, Q. Zhang, J. Glenn, C. Oseroff, I. N. Mbawuike, J. Alexander, M. J. Newman, H. Grey, et al. Immunomic Analysis of the Repertoire of T-Cell Specificities for Influenza A Virus in Humans J. Virol., December 15, 2008; 82(24): 12241 - 12251. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. V. Ganusov and R. J. De Boer Estimating In Vivo Death Rates of Targets due to CD8 T-Cell-Mediated Killing J. Virol., December 1, 2008; 82(23): 11749 - 11757. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Kotturi, I. Scott, T. Wolfe, B. Peters, J. Sidney, H. Cheroutre, M. G. von Herrath, M. J. Buchmeier, H. Grey, and A. Sette Naive Precursor Frequencies and MHC Binding Rather Than the Degree of Epitope Diversity Shape CD8+ T Cell Immunodominance J. Immunol., August 1, 2008; 181(3): 2124 - 2133. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-F. Wang, J. Kerzerho, O. Adotevi, H. Nuyttens, C. Badoual, G. Munier, S. Oudard, S. Tu, E. Tartour, and B. Maillere Comprehensive Analysis of HLA-DR- and HLA-DP4-Restricted CD4+ T Cell Response Specific for the Tumor-Shared Antigen Survivin in Healthy Donors and Cancer Patients J. Immunol., July 1, 2008; 181(1): 431 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Oseroff, B. Peters, V. Pasquetto, M. Moutaftsi, J. Sidney, V. Panchanathan, D. C. Tscharke, B. Maillere, H. Grey, and A. Sette Dissociation between Epitope Hierarchy and Immunoprevalence in CD8 Responses to Vaccinia Virus Western Reserve J. Immunol., June 1, 2008; 180(11): 7193 - 7202. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lundegaard, O. Lund, C. Kesmir, S. Brunak, and M. Nielsen Modeling the adaptive immune system: predictions and simulations Bioinformatics, December 15, 2007; 23(24): 3265 - 3275. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |